Skip to main content
Equibles

Yanina Grant-Huerta

Chief Accounting Officer

Atara Biotherapeutics, Inc. (ATRA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Atara Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ATRA alerts

About Yanina Grant-Huerta

Yanina Grant-Huerta is recorded as Chief Accounting Officer at Atara Biotherapeutics, Inc. (ATRA) since March 31, 2025. Atara Biotherapeutics, Inc. reported in an 8-K filed June 26, 2026 that Yanina Grant-Huerta was terminated as Chief Accounting Officer, effective July 17, 2026. Atara Biotherapeutics, Inc. reported in an 8-K filed March 31, 2025 that Yanina Grant-Huerta was appointed Chief Accounting Officer, effective March 31, 2025. Atara Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Atara Biotherapeutics, Inc. includes AnhCo "Cokey" Thieu Nguyen (CEO), AnhCo Nguyen (CEO and Board Member), Cokey Nguyen (CEO) and 7 others.

“On June 22, 2026, Atara Biotherapeutics, Inc. (the “Company”) notified Yanina Grant-Huerta, the Company’s Chief Accounting Officer, that her employment with the Company would end effective July 17, 2026.”
Atara Biotherapeutics, Inc. Form 8-K, filed June 26, 2026 · Read the filing
“On March 31, 2025, the Company appointed Yanina Grant-Huerta as the Company's Chief Accounting Officer and principal accounting officer, effective March 31, 2025.”
Atara Biotherapeutics, Inc. Form 8-K, filed March 31, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Atara Biotherapeutics, Inc.

Recent activity